Want to see JP:7634 full AI Analyst Report?
7634 Stock Chart & Stats
¥5110.00
-¥15.00(-0.35%)
At close: 4:00 PM EST
¥5110.00
-¥15.00(-0.35%)
Day’s Range― - ―
52-Week Range¥4,500.00 - ¥6,000.00
Previous CloseN/A
Volume400.00
Average Volume (3M)1.10K
Market Cap
¥16.38B
Enterprise Value¥5.23B
Total Cash (Recent Filing)¥11.21B
Total Debt (Recent Filing)¥1.28B
Price to Earnings (P/E)12.1
Beta0.17
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.7%
Share Statistics
EPS (TTM)439.59
Shares Outstanding3,420,000
10 Day Avg. Volume1,120
30 Day Avg. Volume1,096
Financial Highlights & Ratios
PEG Ratio-1.90
Price to Book (P/B)0.82
Price to Sales (P/S)1.06
P/FCF Ratio7.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a rising equity base provide durable financial flexibility: supports capital spending for devices, funds installed-base service and consumables, and reduces default risk. This conservatism underpins long-term stability and makes the business resilient to cyclical shocks.
Steady Revenue And Resilient MarginsConsistent revenue growth together with sustained high-40% gross margins indicates durable product competitiveness and pricing power in respiratory equipment. That mix supports recurring consumables/services revenue and preserves operating profit potential over a multi-quarter horizon.
Healthy Cash GenerationPersistent positive operating cash flow and significant free cash flow coverage of earnings provide funding for maintenance capex, aftermarket service, and shareholder distributions. This supports durable self-funding of the installed-base business and lowers refinancing risk.
Bears Say
ROE / Net Margin Softness In 2026A drop in net margin and ROE despite revenue growth suggests rising costs, mix shifts, or below-the-line pressures. If earnings don't keep pace with the expanding equity base, returns on capital may remain depressed, limiting reinvestment efficiency and long-term shareholder returns.
Free Cash Flow VolatilityIntermittent declines in free cash flow and moderate conversion of earnings to operating cash imply working-capital swings or timing effects. This variability can constrain predictable reinvestment in service networks or product development and complicate capital allocation decisions.
Modest Top-line Growth And EPS DeclineLow single-digit revenue growth alongside negative EPS growth indicates limited organic expansion or margin pressure. Over several quarters this could restrain scale economies, slow aftermarket revenue gains, and reduce flexibility to invest for structural market share gains.
7634 FAQ
What was Hoshi Iryosanki Co., Ltd.’s price range in the past 12 months?
Hoshi Iryosanki Co., Ltd. lowest stock price was ¥4500.00 and its highest was ¥6000.00 in the past 12 months.
What is Hoshi Iryosanki Co., Ltd.’s market cap?
Hoshi Iryosanki Co., Ltd.’s market cap is ¥16.38B.
When is Hoshi Iryosanki Co., Ltd.’s upcoming earnings report date?
Hoshi Iryosanki Co., Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 8 days.
How were Hoshi Iryosanki Co., Ltd.’s earnings last quarter?
Hoshi Iryosanki Co., Ltd. released its earnings results on May 11, 2026. The company reported ¥135.91 earnings per share for the quarter, beating the consensus estimate of N/A by ¥135.91.
Is Hoshi Iryosanki Co., Ltd. overvalued?
According to Wall Street analysts Hoshi Iryosanki Co., Ltd.’s price is currently Overvalued.
Does Hoshi Iryosanki Co., Ltd. pay dividends?
Hoshi Iryosanki Co., Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 1.7%. See more information on Hoshi Iryosanki Co., Ltd. dividends here
What is Hoshi Iryosanki Co., Ltd.’s EPS estimate?
Hoshi Iryosanki Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hoshi Iryosanki Co., Ltd. have?
Hoshi Iryosanki Co., Ltd. has 3,420,000 shares outstanding.
What happened to Hoshi Iryosanki Co., Ltd.’s price movement after its last earnings report?
Hoshi Iryosanki Co., Ltd. reported an EPS of ¥135.91 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.335%.
Which hedge fund is a major shareholder of Hoshi Iryosanki Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7634
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hoshi Iryosanki Co., Ltd.
Hoshi Iryo-Sanki Co., Ltd., a Japanese firm, specializes in the production and distribution of pharmaceutical-grade medical oxygen and nitrous oxide. Its business activities are structured across five distinct divisions: Medical Gas, Home Healthcare, Medical Gas Equipment Construction, Nursing Care, and Facilities Nursing. The Medical Gas division primarily handles the sale of various medical gases, including oxygen and anesthetic gases. Through its Home Healthcare division, the company offers rental services for essential medical devices, such as oxygen concentrators for home therapy, continuous positive airway pressure (CPAP) machines, and home ventilators. The Medical Gas Equipment Construction segment is responsible for the planning, installation, and subsequent maintenance and inspection of medical gas piping systems. The Nursing Care division provides a comprehensive suite of services, encompassing the rental and sale of care-related products, home modifications, and direct nursing assistance through home visits and in-home care coordination. Lastly, the Facilities Nursing division manages and operates fee-based residential nursing homes and day care centers, along with other related services. Established in 1960, the company's main offices are situated in Tokyo, Japan.
Technical Analysis
Medical System Network Co., Ltd.
―
Techno Medica Co., Ltd.
―
Japan Medical Dynamic Marketing, Inc.
―
Precision System Science Co.,Ltd
―
Seed Co., Ltd.
―